Considering our current data and the fact that autophagy is impaired in IBD patients, we further examined whether upregulated claudin-2 levels in IBD patients is due primarily to inhibition of autophagy-targeted claudin-2 degradation. Here, CLDN2 is linked to inflammatory bowel disease.